I am a
Home I AM A Search Login

Papers of the Week


Papers: 4 Jan 2020 - 10 Jan 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 03


Pediatr Neurol


104

Intranasal Ketamine for Abortive Migraine Therapy in Pediatric Patients: A Single-Center Review.

Authors

Turner AL, Shandley S, Miller E, Perry SM, Ryals B
Pediatr Neurol. 2020 03; 104:46-53.
PMID: 31902550.

Abstract

Ketamine has recently emerged as a promising therapeutic alternative for abortive migraine therapy, likely secondary to N-methyl-d-aspartate antagonism. Most reports examine adults and the intravenous route. Fewer utilize intranasal administration or pediatric populations. Given the limited evidence for intranasal ketamine in pediatric migraine populations, we retrospectively reviewed our experience to further characterize safety and efficacy of intranasal ketamine in this population.